SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agenus (AGEN)
AGEN 3.965-0.1%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Dodgy Ticker who wrote (1)1/26/2004 7:12:13 PM
From: Area51  Read Replies (1) of 146
 
I remember that Reuter's article (Armen speculating on a big partnership deal for Oncophage) and it was responsible for rekindling my interest in AGEN. It was good for a good one day move in the stock, but it went right back down. I'm not sure if the market discounted the information as unreliable (interviewer putting words in Armen's mouth) or as idle speculation. Any market value for Oncophage is dependent upon when one thinks Oncophage will be approved, what sort of survival benefit it will provide, and what sales can be expected. I'd be more interested in speculation on those issues than on speculation of partnership terms.

Best Regards,
Area51
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext